About
Chas Eggert is an Operating Partner at iSelect Fund. He previously served as an operating partner at Arsenal Capital Partners and as a managing director and specialty chemical sector leader at Akoya Capital Partners, and was CEO and board director of OPX Biotechnologies, which Cargill acquired. Earlier in his career he spent over 20 years at Monsanto, rising to vice president of Monsanto Venture Capital. He holds a BS in chemical engineering and an MBA from Washington University in St. Louis and an MS in biochemical engineering from the University of Minnesota.
Invests in
BiotechNew Materials
Experience
- RYAMBoard Directorcurrent2022 — present
- Fathers & Families Support CenterBoard Chaircurrent2021 — present
- iSelect FundOperating Partnercurrent2019 — presentSt. Louis
- National Association of Corporate Directors (NACD)Governance Fellowcurrent2015 — presentSt. Louis
- CP KelcoBoard Director2020 — 2024Atlanta
- J.M. Huber CorporationBoard Director, Huber Engineered Materials2013 — 2020Atlanta
- Arsenal Capital PartnersOperating Partner2016 — 2019New York City
- Solvaira Specialties Inc.President and CEO; Board Director2016 — 2017St. Louis
- Akoya Capital Partners, LLCOperating Partner - Specialty Chemicals2014 — 2016Greater St. Louis
- OPX Biotechnologies IncChief Executive Officer and Board Director2008 — 2014Boulder, CO
- Akzo NobelPresident, Specialty Polymers Group2008Bridgewater, NJ
- ICI - National Starch and Chemical Co.Group Vice President, Specialty Polymers2004 — 2008Bridgewater, NJ
- ICI - National Starch and Chemical Co.Vice President and General Manager, Food Ingredients - Europe2002 — 2004London, UK
- ICI - National Starch and Chemical Co.Vice President and General Manager, Personal Care1999 — 2002Bridgewater, NJ
- Engelhard CorporationVice President, Marketing and Sales1997 — 1999Iselin, NJ
- MonsantoDirector Roles - Marketing and Business Management1987 — 1997St. Louis, MO
- MonsantoManager Roles - Technology, Manufacturing, Business Development, Marketing1977 — 1987St. Louis, MO
Skills & more
Mergers4Commercialization44Biotechnology39Technology Transfer19Product Development30Market Development10Strategic Leadership7Polymers45Start-ups22Biofuels14Venture Capital7Cleantech4
+5 more
StrategyStrategic PlanningMergers & AcquisitionsInternational BusinessExecutive Management- Governance Fellow — NACD (National Association of Corporate Directors)
From Chas's professional profile.
Colleagues at iSelect Fund
Carter Williams
CEO and Managing Principal at iSelect Fund
Craig Herron
Managing Principal at iSelect Fund
David Yocom
Associate at iSelect Fund
Eva Tucker
Director of Marketing at iSelect Fund
Holly Hill
Director of Operations at iSelect Fund
Jay Meyer
Director of Technology at iSelect Fund
Joan LaRovere
Operating Partner at iSelect Fund
Mark McCall
Managing Director at iSelect Fund
Frequently asked questions
- Who is Chas Eggert?
- Chas Eggert is an Operating Partner at iSelect Fund. He previously served as an operating partner at Arsenal Capital Partners and as a managing director and specialty chemical sector leader at Akoya Capital Partners, and was CEO and board director of OPX Biotechnologies, which Cargill acquired. Earlier in his career he spent over 20 years at Monsanto, rising to vice president of Monsanto Venture Capital. He holds a BS in chemical engineering and an MBA from Washington University in St. Louis and an MS in biochemical engineering from the University of Minnesota.
- Where does Chas Eggert work?
- Chas Eggert is Operating Partner at iSelect Fund.
- What does Chas Eggert invest in?
- Chas Eggert invests in Biotech, New Materials.
- Where did Chas Eggert go to school?
- Chas Eggert studied at Washington University in St. Louis - Olin Business School (MBA, Marketing & Finance); University of Minnesota (MSChE, Biochemical Engr); Washington University in St. Louis (BSChE).
Same school
Also attended Washington University in St. Louis - Olin Business School52
Steve BrotmanManaging Partner, Founder at Alpha PartnersElyse RossiDirector of Finance Operations at Red Cell IncubationSean AinsworthBiotech CEO at FemHealth VenturesAaron SamuelsInvestor, Entrepreneur, Artist, StorytellerHeather WidmanPartner at Building VenturesRick HoltonCo-Founder at FINTOP Capital
+ 46 more
Also attended University of Minnesota119
Madeline PopeSenior Associate, Platform & Marketing at March Capital PartnersNate LeeFounder and Chief Information Security Officer at Scale Venture PartnersIsaac ZikeManaging Director at RiverVest Venture PartnersRichard HeymanVenture Partner at ARCH Venture PartnersJohn BergstromInvestor at Mairs & Power VCMark GorenbergInvestor at Zetta Venture Partners
+ 113 more
Also attended Washington University in St. Louis174
Lee FixelFounder of AdditionMax WechterSenior Director of AI at Lerer HippeauMark LevinRetired Founding Partner at Third Rock VenturesJess OynickHead of Talent at Union Square Ventures (USV)Andrew ForysiakOwner, AJF and Associates at Riphean InvestmentsRochelle WalenskyExecutive Partner at Flare Capital Partners
+ 168 more
Shared employers
Also worked at Arsenal Capital Partners11
Marin LangSenior Associate at .406 VenturesShane WallPartner & President of CXO Network at FusionCamille WigginsSenior Analyst at CVS Health VenturesJohn ReyndersChief Data Scientist & Venture Partner at Iaso VenturesConnie HeilPrincipal at Brighton Park CapitalChee-We NgManaging Partner at Oakseed Ventures
.png)
+ 5 more
Also worked at Akzo Nobel11
Rasmus AreskougInvestor at DN CapitalRob van der MeijPartner at Capricorn Venture PartnersDick SietsesInvestment Partner Health at Capricorn Venture PartnersArun RambocusCFO/COO at Maven 11Fred van BeuningenManaging Partner at ChrysalixSofia KocherSeed Investment Manager at Chalmers Ventures AB
+ 5 more
Also worked at Monsanto34
Derek RappInvestor at RiverVest Venture PartnersRick RyanGeneral Partner at Cultivation CapitalMartha SchlicherGeneral Partner at Cultivation CapitalNick RosaInvestor at Sandbox IndustriesJohn HamerManaging Partner, DCVC Bio at DCVC (Data Collective)Bob ShapiroManaging Director at Cultivian Sandbox Ventures
+ 28 more